395 related articles for article (PubMed ID: 34737743)
1. Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19.
Khwatenge CN; Pate M; Miller LC; Sang Y
Front Immunol; 2021; 12():732913. PubMed ID: 34737743
[TBL] [Abstract][Full Text] [Related]
2. The Centrality of Obesity in the Course of Severe COVID-19.
Liu D; Zhang T; Wang Y; Xia L
Front Endocrinol (Lausanne); 2021; 12():620566. PubMed ID: 33776917
[TBL] [Abstract][Full Text] [Related]
3. Could targeting immunometabolism be a way to control the burden of COVID-19 infection?
Berber E; Sumbria D; Rouse BT
Microbes Infect; 2021; 23(2-3):104780. PubMed ID: 33482357
[TBL] [Abstract][Full Text] [Related]
4. The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia.
Holder K; Reddy PH
Neuroscientist; 2021 Aug; 27(4):331-339. PubMed ID: 32981462
[TBL] [Abstract][Full Text] [Related]
5. The Weight of Obesity in Immunity from Influenza to COVID-19.
Andrade FB; Gualberto A; Rezende C; Percegoni N; Gameiro J; Hottz ED
Front Cell Infect Microbiol; 2021; 11():638852. PubMed ID: 33816341
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of microRNA-146a in diabetes, obesity and hypertension may contribute to severe COVID-19.
Roganović J
Med Hypotheses; 2021 Jan; 146():110448. PubMed ID: 33338955
[TBL] [Abstract][Full Text] [Related]
7. Impact of Diabetes in Patients Diagnosed With COVID-19.
Abu-Farha M; Al-Mulla F; Thanaraj TA; Kavalakatt S; Ali H; Abdul Ghani M; Abubaker J
Front Immunol; 2020; 11():576818. PubMed ID: 33335527
[TBL] [Abstract][Full Text] [Related]
8. Gene signatures of autopsy lungs from obese patients with COVID-19.
Santos E Silva JC; Vasconcelos AP; Noma IHY; Noronha NY; Aquino R; Giddaluru J; Durão L; Costa-Martins AG; Schuch V; Moraes-Vieira PM; Nakaya HI
Clin Nutr ESPEN; 2021 Aug; 44():475-478. PubMed ID: 34330510
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances.
Westheim AJF; Bitorina AV; Theys J; Shiri-Sverdlov R
Obes Rev; 2021 Oct; 22(10):e13313. PubMed ID: 34269511
[TBL] [Abstract][Full Text] [Related]
10. The Role of Obesity in the Immunopathogenesis of COVID-19 Respiratory Disease and Critical Illness.
Kuperberg SJ; Navetta-Modrov B
Am J Respir Cell Mol Biol; 2021 Jul; 65(1):13-21. PubMed ID: 33797351
[TBL] [Abstract][Full Text] [Related]
11. Obesity pandemic during COVID-19 outbreak: Narrative review and future considerations.
Cava E; Neri B; Carbonelli MG; Riso S; Carbone S
Clin Nutr; 2021 Apr; 40(4):1637-1643. PubMed ID: 33765600
[TBL] [Abstract][Full Text] [Related]
12. Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients.
Frasca D; Reidy L; Cray C; Diaz A; Romero M; Kahl K; Blomberg BB
PLoS One; 2021; 16(3):e0245424. PubMed ID: 33760825
[TBL] [Abstract][Full Text] [Related]
13. How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?
Kumar V
Int Rev Immunol; 2021; 40(1-2):72-107. PubMed ID: 33155525
[TBL] [Abstract][Full Text] [Related]
14. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Bouayad A
Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention.
Sharma JR; Yadav UCS
Obes Res Clin Pract; 2021; 15(2):163-171. PubMed ID: 33509701
[TBL] [Abstract][Full Text] [Related]
16. Obesity, COVID-19 and innate immunometabolism.
Gleeson LE; Roche HM; Sheedy FJ
Br J Nutr; 2021 Mar; 125(6):628-632. PubMed ID: 32892755
[TBL] [Abstract][Full Text] [Related]
17. Obesity and Higher Risk for Severe Complications of Covid-19: What to do when the two pandemics meet.
Valerio A; Nisoli E; Rossi AP; Pellegrini M; Todesco T; El Ghoch M
J Popul Ther Clin Pharmacol; 2020 Jun; 27(S Pt 1):e31-e36. PubMed ID: 32650354
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.
Landstra CP; de Koning EJP
Front Endocrinol (Lausanne); 2021; 12():649525. PubMed ID: 34220706
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2-specific virulence factors in COVID-19.
Kumar A; Prasoon P; Kumari C; Pareek V; Faiq MA; Narayan RK; Kulandhasamy M; Kant K
J Med Virol; 2021 Mar; 93(3):1343-1350. PubMed ID: 33085084
[TBL] [Abstract][Full Text] [Related]
20. Sympathetic activation: a potential link between comorbidities and COVID-19.
Porzionato A; Emmi A; Barbon S; Boscolo-Berto R; Stecco C; Stocco E; Macchi V; De Caro R
FEBS J; 2020 Sep; 287(17):3681-3688. PubMed ID: 32779891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
